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First description of seasonality of birth and
diagnosis amongst teenagers and young adults
with cancer aged 15–24 years in England,
1996–2005
Marlous van Laar1, Sally E Kinsey2,3, Susan V Picton3 and Richard G Feltbower1*
Abstract
Background: We aimed to examine evidence for an infectious aetiology among teenagers and young adults
(TYA) by analysing monthly seasonality of diagnosis and birth amongst 15–24 year olds diagnosed with cancer
in England.
Methods: Cases of leukaemia, lymphoma and central nervous system (CNS) tumours were derived from the
national TYA cancer register (1996–2005). Incidence rates (IR) and trends were assessed using Poisson
regression. Seasonality of diagnosis and birth was assessed using Poisson and logistic regression respectively
with cosine functions of varying periods.
Results: There were 6251 cases diagnosed with leukaemia (n = 1299), lymphoma (n = 3070) and CNS tumours
(n = 1882), the overall IR was 92 (95% CI 89–96) per 1,000,000 15–24 year olds per year.
There was significant evidence of seasonality around the time of diagnosis for Hodgkin’s lymphoma (P < 0.001)
with a peak in February, and for ‘other CNS tumours’ (P = 0.010) with peaks in December and June. Birth peaks
for those with ‘other Gliomas’ (Gliomas other than Astrocytoma and Ependymoma) were observed in May and
November (P = 0.015).
Conclusion: Our novel findings support an infectious aetiological hypothesis for certain subgroups of TYA
cancer in England. Further work will examine correlation with specific infections occurring around the time of
birth and diagnosis within certain diagnostic groups.
Keywords: Cancer, Epidemiology, Seasonal, Adolescents
Background
There is increasing evidence that environmental factors,
such as infections, which vary seasonally and occur
around the time of cancer diagnosis or around the time
of birth, may affect subsequent development of cancer.
This hypothesis can be tested by assessing temporal vari-
ation in cancer incidence as well as seasonality around
the month of diagnosis and the month of birth amongst
those with cancer; evidence for seasonality could reflect
seasonal variation of infections.
Several studies worldwide have looked at seasonal pat-
terns of cancer diagnosis. Summer peaks of ALL diagno-
ses have been observed amongst children and adults in
East Anglia, [1] as well as for children across the UK,
but only for diagnosis between 1953 and 1962. Summer
peaks of ALL diagnoses as well as diagnoses of rhabdo-
myosarcoma and hepatoblastoma have been observed
amongst children in the USA, and a winter peak for cen-
tral nervous system (CNS) tumours diagnosed amongst
children in southern USA [2]. Seasonal variation in
month of diagnosis amongst children and adolescents
for Hodgkin’s disease (HD) has been observed in
Denmark with a peak in March [3]. Amongst adults,
there is evidence of seasonality of diagnosis in England
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of monocytic leukaemia with a peak in February and
March, and in Sweden melanoma diagnosis peak in
May/June and September/October, prostate cancer diagno-
sis peak in October and breast cancer diagnosis peak in
November [4,5].
Previous research has shown evidence for seasonality
around the time of birth in relation to childhood cancer.
For example, children diagnosed with acute lymphoblastic
leukaemia aged 1–6 years in the North of England
exhibited seasonality of birth, with peaks in February and
March, [6,7] and a study from Hungary showed seasonal-
ity of birth amongst 0–4 year olds with ALL with peaks
in February and August [8]. In contrast, several studies
found no evidence of seasonality for ALL or by diagnostic
group amongst children [9,10].
No studies have examined whether there is evidence of
seasonality around the time of birth specifically amongst
teenagers and young adults (TYA) with cancer, despite a
number of papers studying these effects in childhood
cancer. Although there are some studies which cover the
childhood and adolescent age range for seasonality
around the time of diagnosis, non focus solely on teen-
agers and young adults.
We examined evidence for any cyclical variation in
temporal trends in TYA cancer incidence as well as
monthly variation in months of diagnosis and birth, using
a national cancer register of TYAs in England. We report
findings from the first study to examine seasonality of
cancer around birth and diagnosis specifically focused on
the TYA age group, and as such we explored seasonal
patterns in the three main tumour groups (leukaemia,
lymphoma and CNS tumours) and their major subtypes
for which evidence of seasonality already exists within
the childhood cancer literature.
Methods
Data
Cases of leukaemia, lymphoma and central nervous sys-
tem (CNS) tumours amongst 15–24 year olds diagnosed
between 1996 and 2005 in England were obtained from
the national TYA database. Data for this study were pro-
vided by the North West Cancer Intelligence Service fol-
lowing approval for the release of this information from
the National Information Governance Board for Health
and Social Care. Ethical approval for this study was
obtained from Bradford Research Ethics Committee
(Ref: 09/H1302/37). Yearly population data for 15–24
year olds by gender between 1996 and 2005 and month-
specific birth populations per year from 1972 to 1990
were obtained from the office for national statistics. Birth
populations by month and sex were not available, there-
fore, the distribution of males and females by year was
used to estimate sex-specific birth population estimates
for each month.
Statistical methods
Incidence rates and trends were examined overall and by
diagnostic subgroups. Incidence rates per 1,000,000 per
year and 95% confidence intervals (CI) were calculated
using yearly population figures from 1996–2005 and ad-
justed for sex. Incidence trends were assessed by deriv-
ing the average annual percentage change (AAPC) in
incidence rates using sex-adjusted Poisson regression
models, cyclical trends were assessed using Joinpoint re-
gression analysis [11].
Seasonality of diagnosis was assessed by modelling
the number of diagnoses by month using Poisson re-
gression with the inclusion of cosine curves of 12 and
6 month periods (harmonic curves). Seasonality of birth
was assessed by modelling the number of cases born in a
certain month compared to the total monthly birth popu-
lation at risk using logistic regression with the inclusion
of harmonic curves of 12 and 6 month periods. As our
data is restricted to both the age range at diagnosis and
the year of diagnosis (15–24 year olds diagnosed between
1996 and 2005), the birth population at risk for each year
is calculated as follows;
Birth population at riskmonthi ;yearj
¼
Total birthsmonthi ;year j
n
 !

Xn
k¼1
ak
 !
Where birth year j ranges from 1972–1990, n is the
total number of diagnosis years (n = 10; 1996–2005) and
α is the possible age for those born in year j who fall into
the 15–24 age range between 1996 and 2005.
For example, a person born in January 1973 will be aged
23 in 1996 and 24 in 1997. Thus the birth population at risk
in January 1973 is Birth population in January 1973
10
 
 23þ 24ð Þ.
Alongside goodness of fit statistics, we calculated
Akaike’s information criterion (AIC) to determine the best
fitting model in each case. The analysis was completed for
all cases of leukaemia, lymphoma and central nervous sys-
tem (CNS) tumours combined, as well as each major
tumour group and subgroup as defined by the classifica-
tion scheme for tumours diagnosed in adolescents and
young adults [12]. Models were originally adjusted for
sex, and subsequent analyses stratified by sex, allowing
for varying seasonal patterns between groups. Seasonality
was assessed by testing the significance of the peak(s)
with the use of a likelihood ratio test, comparing models
with a constant rate of cases per birth population at risk
to the corresponding harmonic models for seasonality
around the month of birth.
Results
There were a total of 6251 cases of leukaemia, lymphoma
and central nervous system tumours diagnosed amongst
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15–24 year olds between 1996 and 2005 in England. Table 1
gives the incidence rates and average annual percentage
changes by diagnostic group. The overall incidence rate
(IR) is 92 (95%CI 89–96) per 1,000,000 per year. Lymph-
oma has the highest incidence amongst this age group
(IR = 45; 95%CI 43–48 per 1,000,000 per year). There
were no significant AAPC’s for any diagnostic group, ex-
cept for a significant annual 6.82% increase amongst un-
specified central nervous system tumours. No cyclical
trends were observed between 1996 and 2005 in inci-
dence overall or for any individual diagnostic group.
Table 2 gives the results of the Poisson regression
models to assess seasonality around the time of cancer
diagnosis. The best fitting model is given in each case,
with either 12 or 6 month periods. We observed signifi-
cant evidence of a 12 monthly seasonal effect in those
diagnosed with lymphoma overall (P = 0.008) which was
driven by Hodgkin’s lymphoma (P < 0.001) with peaks in
February, and a 6 monthly seasonal effect in those diag-
nosed with other CNS tumours (P = 0.010) with peaks in
December and June (Figure 1). The goodness of fit test
gave P-values of 0.716, 0.580 and 0.305 respectively, in-
dicating no evidence of any lack of model fit. When
stratifying the analysis by sex, we observed significant
seasonal effects of diagnosis with a 12 monthly cycle
amongst males diagnosed with leukaemia (P = 0.020; peak
in October) and Hodgkin’s lymphoma (P = 0.005; peak in
February) and seasonality with a 6 month cycle for male
diagnosis of astrocytoma (P = 0.043; peaks in April and
October) and other CNS tumours (P = 0.018; peaks in
January and July) (Figure 2). Amongst females, there was
evidence of seasonality in month of diagnosis of lymphoma
(P = 0.017; peak in February) and Hodgkin’s lymphoma
(P = 0.013; peak in February), and evidence of a 6-monthly
seasonal effect of medulloblastoma diagnoses (P = 0.032;
peaks in March and September) (Figure 3). All goodness of
fit statistics showed adequate model fit (P > 0.05)
Table 3 gives results of the sex adjusted logistic regres-
sion models including tests for seasonality of birth with 12
and 6 month periods. There was no evidence of seasonality
with a 12 month period amongst any of the diagnostic
groups. We observed significant evidence of a 6 monthly
seasonal effect amongst those with ‘other Gliomas’ such
that there were maximums in May and November and
minimums in February and August (P = 0.015) (Figure 4).
The goodness of fit test gives a P-value of 0.874, indicating
good model fit. When stratifying the analysis by sex, we
observed significant seasonal effects in males with non-
Hodgkin’s lymphoma (peaks in January and July; P = 0.040)
and CNS tumours (peaks in December and June; P =
0.006); no seasonality was present in females (Figure 5).
Discussion
This is the first national population based analysis in
England which focuses specifically on seasonality of
birth and diagnosis amongst TYAs with cancer.
Table 1 Incidence rates and temporal trends for 15–24 year olds diagnosed with cancer in England, 1996-2005
Incidence rates2 Temporal trends
Diagnostic group1 Cases (N) Rate (95% CI) AAPC P-value
Leukaemia 1299 17 (16–19) 0.12% 0.901
ALL 591 6 (6–7) 1.20% 0.401
AML 463 7 (6–8) −1.47% 0.357
CML 147 2 (1–2) 4.98% 0.091
Other Leukaemia 98 1 (1–2) −5.71% 0.095
Lymphoma 3070 45 (43–48) 1.17% 0.063
Hodgkin Lymphoma 2079 33 (31–35) 1.96% 0.078
Non-Hodgkin Lymphoma 991 12 (11–13) 0.79% 0.297
CNS Tumours 1882 29 (27–31) 0.37% 0.644
Astrocytoma 629 9 (8–10) −0.58% 0.674
Other Gliomas 195 3 (2–3) 2.23% 0.374
Ependymoma 99 2 (1–2) 3.53% 0.321
Medulloblastoma 111 2 (1–2) −2.68% 0.406
Other CNS 702 12 (11–14) −0.50% 0.702
Unspecified CNS 2 (2–3) 6.82% 0.023
Leukaemia, Lymphoma, CNS tumours 6251 92 (89–96) 0.71% 0.106
1 Based on the classification scheme for tumours diagnosed in adolescents and young adults [12].
2Sex-adjusted rate per 1,000,000 per year.
CI: Confidence interval, AAPC: Average annual percentage change.
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Table 2 Sex-adjusted monthly seasonality of diagnosis in cancer amongst 15–24 year olds in England, 1996–2005
Harmonic model results2
Diagnostic group1 Cases (N) Max Min P-value3 GOF (P-value) Period (Months)
Leukaemia 1299 Oct Apr 0.266 0.461 12
ALL 591 Oct Apr 0.253 0.780 12
AML 463 Nov May 0.498 0.354 12
CML 147 Jan, Jul Apr, Oct 0.651 0.690 6
Other Leukaemia 98 Feb, Aug May, Nov 0.424 0.528 6
Lymphoma 3070 Feb Aug 0.008 0.716 12
Hodgkin Lymphoma 2079 Feb Aug <0.001 0.580 12
Non-Hodgkin Lymphoma 991 Feb Aug 0.667 0.968 12
CNS Tumours 1882 Sep Mar 0.653 0.638 12
Astrocytoma 629 Dec, Jun Mar, Sep 0.479 0.730 6
Other Gliomas 195 Sep Mar 0.091 0.942 12
Ependymoma 99 Jan Jul 0.612 0.988 12
Medulloblastoma 111 Dec, Jun Mar, Sep 0.080 0.640 6
Other CNS 702 Dec, Jun Mar, Sep 0.010 0.305 6
Unspecified CNS 146 May, Nov Feb, Aug 0.448 0.657 6
Leukaemia, Lymphoma, CNS tumours 6251 Jan Jul 0.241 0.793 12
1 Based on the classification scheme for tumours diagnosed in adolescents and young adults [12].
2Best fitting model is presented in each case, based on comparison of Akaike’s Information Criterion between models with differing periods.
3Statistical significance of the peaks.
GOF: Goodness of fit statistic.
Figure 1 Sex-adjusted seasonality in month of diagnosis of cancer amongst 15–24 year olds, 1996–2005.
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Figure 2 Seasonality in month of diagnosis for male 15–24 year olds with cancer, 1996–2005.
Figure 3 Seasonality in month of diagnosis for female 15–24 year olds with cancer, 1996–2005.
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There is existing evidence of seasonality around the
time of diagnosis in children with leukaemia, Hodgkin’s
lymphoma and brain tumours as well as some evidence
of seasonality of birth for childhood leukaemia. An infec-
tious aetiology for childhood cancers has been found in
some diagnostic groups. Our study supports an infectious
aetiological hypothesis for certain subgroups of cancer in
TYAs in England.
Our findings show significant evidence of seasonality
by month of diagnosis such that TYAs with Hodgkin’s
lymphoma were most likely to be diagnosed in February.
This pattern was further confirmed in subgroup analysis
by gender for both males and females, and is consistent
with that of a previous study looking at both children
and adolescents under the age of 20 in Denmark which
showed a peak of Hodgkin’s Lymphoma in March [3]. Two
further studies have shown a March peak of Hodgkin’s
lymphoma diagnoses, [13,14] however, these studies cover
all ages and ages 0–79 respectively and did not focus exclu-
sively on the TYA age range.
Although no specific infectious agent has been identi-
fied as a cause for Hodgkin’s lymphoma, there have been
numerous studies which have reported an association
between Hodgkin’s lymphoma and Epstein-Barr virus
(EBV). Mononucleosis is a viral infection usually caused
by EBV, which has been shown to have similar seasonal
patterns as that of Hodgkin’s lymphoma amongst those
under the age of 40, with a peak in March [15].
TYAs diagnosed with tumours classified as ‘other
CNS tumours’ displayed a significant winter and summer
peak overall, which appeared to be driven by males. Win-
ter peaks have been observed in previous childhood stud-
ies of CNS tumours, [2] but not in the TYA age range.
The gender specific analysis further revealed significant
Table 3 Sex-adjusted monthly seasonality of birth in cancer amongst 15–24 year olds in England, 1996-2005
Harmonic Model Results2
Diagnostic group1 Cases (N) Max Min P-value3 GOF (P-value) Period (Months)
Leukaemia 1299 Apr, Oct Jan, Jul 0.242 0.917 6
ALL 591 Apr, Oct Jan, Jul 0.242 0.917 6
AML 463 Jan, Jul Apr, Oct 0.560 0.356 6
CML 147 Jan, Jul Apr, Oct 0.775 0.650 12
Other Leukaemia 98 Jan Jul 0.279 0.527 12
Lymphoma 3070 Jan, Jul Apr, Oct 0.428 0.281 6
Hodgkin Lymphoma 2079 Mar Sep 0.460 0.100 12
Non-Hodgkin Lymphoma 991 Jan, Jul Apr, Oct 0.080 0.468 6
CNS Tumours 1882 May, Nov Feb, Aug 0.155 0.368 6
Astrocytoma 629 Jan Jul 0.119 0.988 12
Other Gliomas 195 May, Nov Feb, Aug 0.015 0.874 6
Ependymoma 99 Dec, Jun Mar, Sep 0.158 0.092 6
Medulloblastoma 111 Jan, Jul Apr, Oct 0.257 0.446 6
Other CNS 702 Apr Oct 0.706 0.116 12
Unspecified CNS 146 Dec Jun 0.753 0.616 12
Leukaemia, Lymphoma, CNS tumours 6251 Jan Jul 0.339 0.405 12
1Based on the classification scheme for tumours diagnosed in adolescents and young adults [12].
2Best fitting model is presented in each case, basedon comparison of Akaike’s Information Criterion between models with differing periods.
3Statistical significance of the peaks.
GOF: Goodness of fit statistic.
Figure 4 Sex-adjusted seasonality in month of birth amongst
15–24 year olds with Other Glioma’s, 1996–2005.
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seasonality of male diagnosis of astrocytoma peaking in
April and October and female diagnosis of medulloblas-
toma peaking in March.
The bi-modal seasonal birth peaks observed in other
CNS tumours (excluding Ependymomas and other
Gliomas) and those amongst males with astrocytoma are
a surprising result given the wide spectrum of clinical be-
haviours within both of these heterogeneous groups,
which include both low and high grade brain tumours.
Infections tend to display seasonal winter peaks, however,
there may be a significant lag time between when the first
cancer symptoms occurred and the date of diagnosis.
Studies looking at the lag time for brain tumours in the
TYA age range give inconsistent results, with a median
reported delay of around 6 weeks in one paper [16] and a
mean lag time of 13 weeks in another [17]. Potential
confounding by delays in diagnosis therefore requires
careful consideration when attempting to interpret these
results. Nonetheless, this novel finding highlights the
need for further aetiological research into CNS tumours
and their subtypes, which are currently under-researched
in this age group.
Additionally, we observed a peak in October for male
diagnoses of leukaemia. Although childhood studies of
seasonality in leukaemia have shown peaks of diagnosis
in summer months, [2] another study for adults has shown
they have peaks in winter months [4] which is similar to
our finding. Differences between the seasonality amongst
childhood leukaemia compared to TYA leukaemia are not
necessarily unexpected, due to the rapidly progressive na-
ture of leukaemia amongst TYAs compared to children
and the changes in disease epidemiology and tumour
biology such that the incidence of ALL decreases and
AML increases when moving through the childhood and
young adult age range.
In addition to seasonality around diagnosis, we also ob-
served significant evidence of seasonality by month of
birth. There were significant peaks in the birth months of
May and November for males and females who developed
‘other Gliomas’ (Gliomas that are not classified as Astrocy-
toma or Ependymoma). This finding was difficult to inter-
pret due to the heterogeneous nature of the ‘other Glioma’
classification containing both low grade Gliomas such as
Oligodendroglioma and Oligoastrocytoma as well as ag-
gressive high grade Gliomas such as Gliomatosis. Small
numbers precluded any further analysis by diagnostic sub-
type. Further seasonal effects around birth were restricted
to males with non-Hodgkin’s lymphoma and males with
CNS tumours, both exhibiting peaks in mid-winter and
mid-summer.
In terms of aetiology, our results suggest that exposures
around the time of diagnosis are more important for TYA
with cancer than environmental factors operating around
the time of birth. This is contrary to epidemiological find-
ings observed amongst childhood cancer diagnosed under
the age of 15. This could be evidence for a more important
role of environmental factors rather than innate factors
alone, due to the increased time period between birth and
diagnosis for TYAs compared to children. More generally,
a viral infection of the mother transmitted in utero to the
foetus may be the precipitating event leading to cancer in
adolescence and young adulthood. This mechanism has
been described for other chronic diseases including Type I
diabetes [18,19] and celiac disease [20].
Figure 5 Seasonality in month of birth amongst male 15–24 year olds with Non-Hodgkin’s Lymphoma (left) and CNS tumours (right),
1996–2005.
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Evidence of seasonality around the month of diagnosis
and month of birth could be explained by a number of fac-
tors; they could be a result of increased routine GP/health
care appointments in winter leading to higher chances of
diagnosis around this time; [21] or to seasonal differences
in dietary consumption, [22] or a response to an infectious
agent acting either around the time of diagnosis or around
the time of birth [23] or they could simply be chance find-
ings due to the number of statistical tests that have been
performed. A limitation of the work is that the analysis did
not include any data on perinatal factors which may influ-
ence the risk of cancer amongst TYAs. Nevertheless, the
consistency with other studies provides greater confidence
that these may be more than chance findings; furthermore,
all models had good model fit statistics.
Population mobility is relatively high for individuals aged
between 15–24, with many moving to college or University
or entering employment for the first time. This may lead to
increased exposure to unknown infections which may vary
in ways which might explain the bi-modal seasonality of
cancer diagnosis observed within this study.
Conclusion
This is the first national population based study in England
focusing specifically on seasonality of birth and diagno-
sis amongst TYAs with cancer. An infectious aetiology
for childhood cancers has already been shown in some
diagnostic groups, however, this study has produced
new findings describing seasonality patterns around the
time of diagnosis and birth amongst the TYA age group
in England.
Our study supports an infectious aetiological hypoth-
esis for certain subgroups of cancer in TYAs in England.
We have shown seasonality in diagnosis of Hodgkin’s
lymphoma and the other CNS tumour subgroup as well
as seasonality in birth for the other glioma subgroup.
This work forms the basis for further investigations into
the infectious aetiology of TYA cancers by examining
correlation with specific infections occurring around
birth (including antenatal exposure to infectious or sea-
sonal environmental factors) and diagnosis within certain
cancer subtypes.
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